Oscar Health (NYSE:OSCR) Rating Lowered to “Equal Weight” at Wells Fargo & Company

Oscar Health (NYSE:OSCR) was downgraded by investment analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating in a research note issued on Thursday, Marketbeat.com reports. They currently have a $16.00 target price on the stock, down from their previous target price of $20.00. Wells Fargo & Company‘s price objective would suggest a potential upside of 20.98% from the stock’s previous close.

Separately, Jefferies Financial Group initiated coverage on Oscar Health in a report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, three have given a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $20.19.

Oscar Health Stock Performance

Shares of NYSE OSCR opened at $13.23 on Thursday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The firm has a market cap of $3.31 billion, a price-to-earnings ratio of -660.92 and a beta of 1.75. The business’s 50-day simple moving average is $15.21 and its 200-day simple moving average is $16.39. Oscar Health has a 52 week low of $12.43 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, equities research analysts expect that Oscar Health will post 0.69 earnings per share for the current fiscal year.

Institutional Trading of Oscar Health

A number of hedge funds have recently modified their holdings of the company. Brooklyn FI LLC bought a new stake in shares of Oscar Health in the 4th quarter worth approximately $441,000. Toronto Dominion Bank bought a new stake in shares of Oscar Health in the 4th quarter worth approximately $1,008,000. Tidal Investments LLC bought a new stake in shares of Oscar Health in the 4th quarter worth approximately $419,000. Thrive Capital Management LLC lifted its position in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after buying an additional 1,588,395 shares during the period. Finally, Scion Asset Management LLC bought a new position in shares of Oscar Health during the 4th quarter worth approximately $2,688,000. Institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.